INCY stock news
This page provides real-time market news, earnings updates, and company announcements related to Incyte Corporation (INCY).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-13 08:08 EST
Incyte: Fourth Quarter Earnings Overview
101 finance2026-02-10 12:30:06
Do financial experts on Wall Street have a favorable opinion of Incyte Corporation shares?
101 finance2026-02-12 11:33:43
Where is Incyte Corporation (INCY) Headed According to Analysts?
Finviz2026-02-19 14:57:45
Incyte Corp. (INCY) Reports Q4 2025 Revenue Growth of 28% to $1.51B Driven by Jakafi and Opzelura Sales
Finviz2026-02-20 09:12:44
Syndax Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-26 21:03:45
Syndax Pharmaceuticals Inc. (SNDX) on a Strong Footing amid Robust Demand for Key Flagship Drugs
Finviz2026-03-02 08:00:49
LLY Receives CHMP Approval for Broader Application of Olumiant in Treating Alopecia Areata
101 finance2026-03-02 17:49:21
Is Now a Good Moment to Include Labcorp Shares in Your Investment Portfolio?
101 finance2026-03-04 14:18:59
Is Now an Ideal Moment to Include Labcorp Shares in Your Investment Portfolio?
101 finance2026-03-04 14:18:59
INCY Receives European Commission Authorization to Broaden Zynyz Oncology Drug Indication
101 finance2026-03-09 17:18:49
MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures
Finviz2026-03-09 20:06:46
Incyte (INCY): Should You Buy, Sell, or Hold After Q4 Results?
101 finance2026-03-11 23:06:41
Qualcomm, Adobe cut: Leading Wall Street analysts weigh in
101 finance2026-03-16 13:45:49
Incyte’s MutCALR Bet: S-Curve Inflection in MPN Infrastructure
101 finance2026-03-19 16:51:58
KPTI Shares Fall Following Varied Results from Phase III Myelofibrosis Combination Study
101 finance2026-03-25 15:30:54
Geron Announces Appointment of New Members to its Board of Directors
Finviz2026-03-26 12:03:45
Incyte's 54-Week Povorcitinib Results: Will They Confirm IAI Franchise Expansion or Trigger a Surge?
101 finance2026-03-28 19:27:40
Incyte presented the latest positive 54-week data on its investigational drug Povorcitinib for the treatment of hidradenitis suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting.
老虎证券2026-03-28 19:32:04
Incyte Shares Positive 54-Week Results From Advanced Skin Condition Trial
101 finance2026-03-30 20:03:40
Incyte's Strategic Leadership Shift May Be Underpriced
101 finance2026-03-30 23:52:04
Incyte Faces Growth Challenges: Will Opzelura Close the $2.4 Billion Jakafi Shortfall?
101 finance2026-03-31 06:01:10
Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination with Incyte's TGFßR2xPD-1 Bispecific Antibody (INCA33890) in Patients with Microsatellite Stable Colorectal Cancer (MSS CRC)
Finviz2026-04-02 11:06:06
Adagene Secures $70M in Funding to Advance Pipeline—But Has the Market Already Factored in the Optimism?
101 finance2026-04-02 12:54:48
Palvella Therapeutics Appoints Accomplished Commercial Leader Kent Taylor as Senior Vice President of Sales
Finviz2026-04-07 11:33:11
Syndax Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-26 21:03:45
Syndax Pharmaceuticals Inc. (SNDX) on a Strong Footing amid Robust Demand for Key Flagship Drugs
Finviz2026-03-02 08:00:49
LLY Receives CHMP Approval for Broader Application of Olumiant in Treating Alopecia Areata
101 finance2026-03-02 17:49:21
Is Now a Good Moment to Include Labcorp Shares in Your Investment Portfolio?
101 finance2026-03-04 14:18:59
Is Now an Ideal Moment to Include Labcorp Shares in Your Investment Portfolio?
101 finance2026-03-04 14:18:59
INCY Receives European Commission Authorization to Broaden Zynyz Oncology Drug Indication
101 finance2026-03-09 17:18:49
MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures
Finviz2026-03-09 20:06:46
Incyte (INCY): Should You Buy, Sell, or Hold After Q4 Results?
101 finance2026-03-11 23:06:41
Qualcomm, Adobe cut: Leading Wall Street analysts weigh in
101 finance2026-03-16 13:45:49
Incyte’s MutCALR Bet: S-Curve Inflection in MPN Infrastructure
101 finance2026-03-19 16:51:58
KPTI Shares Fall Following Varied Results from Phase III Myelofibrosis Combination Study
101 finance2026-03-25 15:30:54
Geron Announces Appointment of New Members to its Board of Directors
Finviz2026-03-26 12:03:45
Incyte's 54-Week Povorcitinib Results: Will They Confirm IAI Franchise Expansion or Trigger a Surge?
101 finance2026-03-28 19:27:40
Incyte presented the latest positive 54-week data on its investigational drug Povorcitinib for the treatment of hidradenitis suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting.
老虎证券2026-03-28 19:32:04
Incyte Shares Positive 54-Week Results From Advanced Skin Condition Trial
101 finance2026-03-30 20:03:40
Incyte's Strategic Leadership Shift May Be Underpriced
101 finance2026-03-30 23:52:04
Incyte Faces Growth Challenges: Will Opzelura Close the $2.4 Billion Jakafi Shortfall?
101 finance2026-03-31 06:01:10
Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination with Incyte's TGFßR2xPD-1 Bispecific Antibody (INCA33890) in Patients with Microsatellite Stable Colorectal Cancer (MSS CRC)
Finviz2026-04-02 11:06:06
Adagene Secures $70M in Funding to Advance Pipeline—But Has the Market Already Factored in the Optimism?
101 finance2026-04-02 12:54:48
Palvella Therapeutics Appoints Accomplished Commercial Leader Kent Taylor as Senior Vice President of Sales
Finviz2026-04-07 11:33:11
INCY stock chart
INCY stock detailsINCY stock price change
On the last trading day, INCY stock closed at 96.07 USD, with a price change of -0.92% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more